Cancer risk in patients aged 30 years and above with type 2 diabetes receiving antidiabetic monotherapy: a cohort study using metformin as the comparator

References

• DanaeiGFinucaneMMLuYNational, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participantsLancet20113789785314021705069
   PubMed Web of Science ®Google Scholar
• VigneriPFrascaFSciaccaLPandiniGVigneriRDiabetes and cancerEndocr Relat Cancer20091641103112319620249
   PubMed Web of Science ®Google Scholar
• NathanDMBuseJBDavidsonMBMedical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of DiabetesDiabetes Care200932119320318945920
   PubMed Web of Science ®Google Scholar
• EvansJMDonnellyLAEmslie-SmithAMAlessiDRMorrisADMetformin and reduced risk of cancer in diabetic patientsBMJ200533075031304130515849206
   PubMed Web of Science ®Google Scholar
• LibbyGDonnellyLADonnanPTAlessiDRMorrisADEvansJMNew users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetesDiabetes Care20093291620162519564453
   PubMed Web of Science ®Google Scholar
• RuiterRVisserLEvan Herk-SukelMPLower risk of cancer in patients on metformin in comparison with those on sulfonylurea derivatives: results from a large population-based follow-up studyDiabetes Care201235111912422100960
   PubMed Web of Science ®Google Scholar
• ThakkarBAronisKNVamviniMTShieldsKMantzorosCSMetformin and sulfonylureas in relation to cancer risk in type II diabetes patients: a meta-analysis using primary data of published studiesMetabolism201362792293423419783
   PubMed Web of Science ®Google Scholar
• ZhangZJZhengZJKanHReduced risk of colorectal cancer with metformin therapy in patients with type 2 diabetes: a meta-analysisDiabetes Care201134102323232821949223
   PubMed Web of Science ®Google Scholar
• ShawRJLamiaKAVasquezDThe kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metforminScience200531057541642164616308421
   PubMed Web of Science ®Google Scholar
• AzoulayLDell’AnielloSGagnonBPollakMSuissaSMetformin and the incidence of prostate cancer in patients with type 2 diabetesCancer Epidemiol Biomarkers Prev201120233734421148757
   PubMed Web of Science ®Google Scholar
• BodmerMBeckerCMeierCJickSSMeierCRUse of metformin is not associated with a decreased risk of colorectal cancer: a case-control analysisCancer Epidemiol Biomarkers Prev201221228028622178569
   PubMed Web of Science ®Google Scholar
• MamtaniRPfanzelterNHaynesKIncidence of bladder cancer in patients with type 2 diabetes treated with metformin or sulfonylureasDiabetes Care20143771910191724496803
   PubMed Web of Science ®Google Scholar
• QiuHRhoadsGGBerlinJAMarcellaSWDemissieKInitial metformin or sulphonylurea exposure and cancer occurrence among patients with type 2 diabetes mellitusDiabetes Obes Metab201315434935723137378
   PubMed Web of Science ®Google Scholar
• SimoRPlana-RipollOPuenteDImpact of glucose-lowering agents on the risk of cancer in type 2 diabetic patients. The Barcelona case-control studyPLoS One2013811e7996824278227
   PubMed Web of Science ®Google Scholar
• SmiechowskiBBAzoulayLYinHPollakMNSuissaSThe use of metformin and the incidence of lung cancer in patients with type 2 diabetesDiabetes Care201336112412922923670
   PubMed Web of Science ®Google Scholar
• van StaaTPPatelDGallagherAMde BruinMLGlucose-lowering agents and the patterns of risk for cancer: a study with the General Practice Research Database and secondary care dataDiabetologia201255365466522127412
   PubMed Web of Science ®Google Scholar
• WalkerEJKoAHHollyEABracciPMMetformin use among type 2 diabetics and risk of pancreatic cancer in a clinic-based case-control studyInt J Cancer20151366E646E65325091126
   PubMed Web of Science ®Google Scholar
• TsilidisKKCapothanassiDAllenNEMetformin does not affect cancer risk: a cohort study in the U.K. Clinical Practice Research Datalink analyzed like an intention-to-treat trialDiabetes Care20143792522253224898303
   PubMed Web of Science ®Google Scholar
• KokVCHorngJTChangWSHongYFChangTHAllopurinol therapy in gout patients does not associate with beneficial cardiovascular outcomes: a population-based matched-cohort studyPLoS One201496e9910224897240
   PubMed Web of Science ®Google Scholar
• KokVCHorngJTHuangJLPopulation-based cohort study on the risk of malignancy in East Asian children with juvenile idiopathic arthritisBMC Cancer20141463425174953
   PubMed Web of Science ®Google Scholar
• KokVCHorngJTLinHLChenYCChenYJChengKFGout and subsequent increased risk of cardiovascular mortality in non-diabetics aged 50 and above: a population-based cohort study in TaiwanBMC Cardiovasc Disord20121210823170782
   PubMed Web of Science ®Google Scholar
• KokVCTsaiHJSuCFLeeCKThe risks for ovarian, endometrial, breast, colorectal, and other cancers in women with newly diagnosed endometriosis or adenomyosis: a population-based studyInt J Gynecol Cancer201525696897625893280
   PubMed Web of Science ®Google Scholar
• EikawaSNishidaMMizukamiSYamazakiCNakayamaEUdonoHImmune-mediated antitumor effect by type 2 diabetes drug, metforminProc Natl Acad Sci U S A201511261809181425624476
   PubMed Web of Science ®Google Scholar
• ZhangZJBiYLiSReduced risk of lung cancer with metformin therapy in diabetic patients: a systematic review and meta-analysisAm J Epidemiol20141801111424920786
   PubMed Web of Science ®Google Scholar
• BuWJSongLZhaoDYGuoBLiuJInsulin therapy and the risk of colorectal cancer in patients with type 2 diabetes: a meta-analysis of observational studiesBr J Clin Pharmacol201478230130925099257
   PubMed Web of Science ®Google Scholar
• CurrieCJPooleCDGaleEAThe influence of glucose-lowering therapies on cancer risk in type 2 diabetesDiabetologia20095291766177719572116
   PubMed Web of Science ®Google Scholar
• NewtonCCGapsturSMCampbellPTJacobsEJType 2 diabetes mellitus, insulin-use and risk of bladder cancer in a large cohort studyInt J Cancer201313292186219123024033
   PubMed Web of Science ®Google Scholar